The Diagnostic and Prognostic Value of the Combination of Tumor M2-Pyruvate Kinase, Carcinoembryonic Antigen, and Cytokeratin 19 Fragment in Non-Small Cell Lung Cancer

MLA

Li Li MD, et al. “The Diagnostic and Prognostic Value of the Combination of Tumor M2-Pyruvate Kinase, Carcinoembryonic Antigen, and Cytokeratin 19 Fragment in Non-Small Cell Lung Cancer.” Technology in Cancer Research & Treatment, vol. 23, July 2024. EBSCOhost, https://doi.org/10.1177/15330338241265983.

APA

Li Li MD, Yihan Xu MS, Yuchao Wang PhD, Qian Zhang MD, Yan Wang MD, & Chunhua Xu MD. (2024). The Diagnostic and Prognostic Value of the Combination of Tumor M2-Pyruvate Kinase, Carcinoembryonic Antigen, and Cytokeratin 19 Fragment in Non-Small Cell Lung Cancer. Technology in Cancer Research & Treatment, 23. https://doi.org/10.1177/15330338241265983

Chicago

Li Li MD, Yihan Xu MS, Yuchao Wang PhD, Qian Zhang MD, Yan Wang MD, and Chunhua Xu MD. 2024. “The Diagnostic and Prognostic Value of the Combination of Tumor M2-Pyruvate Kinase, Carcinoembryonic Antigen, and Cytokeratin 19 Fragment in Non-Small Cell Lung Cancer.” Technology in Cancer Research & Treatment 23 (July). doi:10.1177/15330338241265983.